Grant number: 1202192 | Funding period: 2020 - 2024
Completed
SJV Gordon, F Perner, L Macpherson, KA Fennell, DV Wenge, W Bourgeois, T Klaus, T Plenge, A Murat, J Petrovic, J Horvath, JQ Cao, JD Lapek, S Uryu, JR White, EYN Lam, XJ Mu, YC Chan, A Gillespie, BJ Blyth
2025-10-01
Targeting MYST acetyltransferases is an exciting therapeutic opportunity in acute myeloid leukemia (AML). In this study, we define..